🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Harkaa › Texas

Qorannoo klinikaalii Dhibee Harkaa Texas keessatti

Qorannoo 24 Dhibee Harkaa f Texas keessatti hirmaatuu jiru.

Magaalota Texas keessatti

Takkalaa qorannoo (Ingiliffa)

DESTINY-PANTUMOUR04

  • Research Site, Dallas
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07124000

National Liver Cancer Screening Trial

  • UT Southwestern Medical Center and Parkland Hospital, Dallas
  • Baylor College of Medicine, Houston
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06084234

CREO - Microwave Ablation Feasibility Study

  • Memorial Hermann-Texas Medical Center, Houston
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07817147

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

  • St. David's Medical Center, Austin
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 22 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06486454

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

  • University of Texas Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT04864054

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  • UT MD Anderson, Houston
  • NEXT Oncology, San Antonio
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06440005

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

  • Texas Children's Hospital, Houston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT04715191

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

  • MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07010315

Multi-analyte Blood Test Clinical Trial

  • South Texas Research Institute, Edinburg
  • Texas Gastro Research, El Paso
  • Impact Research Institute, Waco
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ado-2026 · NCT05199259

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

  • NEXT Dallas, Dallas
  • MD Anderson Cancer Center, Houston
  • NEXT Houston, Houston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07337525

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

  • JPS Health Network, Forth Worth
  • Baylor Scott and White Biorepository, Temple
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT07327489

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

  • Clinical Trial Site, Dallas
  • Clinical Trial Site, Houston
  • Clinical Trial Site, San Antonio
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT06600321

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Namoota walitti qabaa jira
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT05486572

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

  • START Dallas, Fort Worth
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT07517198

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • MD Anderson Cancer Center, Houston
  • NEXT Oncology, San Antonio
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT06239194

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

  • MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT06362369

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

  • Md Anderson Cancer Center, Houston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Bit-2026 · NCT04075305

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

  • Baylor College of Medicine, Houston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 0 hanga 30 · Saalaa hunda · Haaromfame 24-Gur-2026 · NCT04134559

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

  • NEXT Dallas, Dallas
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ama-2026 · NCT07317505

Sample Collection for Ongoing Research and Product Evaluation Study

  • Natera, Inc., Austin
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ama-2026 · NCT07318051

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Dallas
  • Massive Bio SYNERGY-AI site, Houston
  • Massive Bio SYNERGY-AI site, Temple
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

EGCG for Hepatocellular Carcinoma Chemoprevention

  • UT Southwestern, Dallas
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Ful-2025 · NCT06015022

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

  • Site 881, Dallas
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Elb-2025 · NCT05201404

Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria

  • Houston Methodist Research Institute, Houston
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Gur-2023 · NCT05185505

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.